COXLEON Capsule Ref.[51231] Active ingredients: Celecoxib

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2021  Publisher: Sandoz SA (Pty) Ltd<sup>1</sup>, Waterfall 5-lr, Magwa Crescent West, Waterfall City, Jukskei View, 2090 1 Company Reg. No.: 1990/001979/07

Product name and form

COXLEON 100 (capsules).

COXLEON 200 (capsules).

Pharmaceutical Form

100 mg: Blue capsule with white body, which contains white to slightly yellowish pellets.

200 mg: Orange capsule with white body, which contains white to slightly yellowish pellets.

Qualitative and quantitative composition

Each COXLEON 100 capsule contains 100 mg celecoxib.

Each COXLEON 200 capsule contains 200 mg celecoxib.

Excipient with known effect:

Each COXLEON 100 capsule contains sugar (7 mg lactose monohydrate).

Each COXLEON 200 capsule contains sugar (14 mg lactose monohydrate).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Celecoxib

Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.

List of Excipients

Carrageenan; lactose monohydrate; magnesium stearate; microcrystalline cellulose; sodium laurilsulfate.

Body composition: gelatine; titanium dioxide.

100 mg cap composition: gelatine; indigo-carmine; titanium dioxide.

200 mg cap composition: gelatine; red iron oxide; titanium dioxide; yellow iron oxide.

Pack sizes and marketing

An outer carton containing transparent PVC/TE/PVDC/silver aluminium blisters.

Pack sizes: COXLEON 100 and COXLEON 200 are packed in 10’s, 30’s and 60’s.

Not all pack sizes may be marketed.

Marketing authorization holder

Sandoz SA (Pty) Ltd1, Waterfall 5-lr, Magwa Crescent West, Waterfall City, Jukskei View, 2090

1 Company Reg. No.: 1990/001979/07

Marketing authorization dates and numbers

COXLEON 100: 46/3.1/0704.702
COXLEON 200: 46/3.1/0705.703

Date of first authorization: 02 June 2017

Drugs

Drug Countries
COXLEON South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.